Targeting the undruggables—the power of protein degraders
Chao Zhang(Shanghai Sunshine Rehabilitation Center), Yu Rao(Soochow University), Guangchen Li(Shandong Jiaotong University), Chunquan Sheng(Second Military Medical University), Xiuyun Sun(Tsinghua University), Chi Han(Dalian Polytechnic University), Ke Ding(China Pharmaceutical University), Zhouli Yang(State Key Laboratory of Molecular Oncology), Yongbo Liu(Changzhi Medical College)
Cited by 90
Related Papers
PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
PROTAC Technology: Opportunities and Challenges
|ACS Medicinal Chemistry Letters|2020|353
PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
|Cell Research|2018|280
Chemistries of bifunctional PROTAC degraders
|Chemical Society Reviews|2022|270